Concepedia

Sharon K. Gershon

SK

Statistics

Publications

7

Citations

5.3K

H-Index

7

Active since

1984

Affiliations

Center for Biologics Evaluation and Research(Current)

United States Food and Drug Administration

Sharon K. Gershon is an author at Center for Biologics Evaluation and Research specializing in immunotherapy, immunology, and rheumatoid arthritis pharmacotherapy.

Publications per year

1984–2010

7

Publications

7

Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

Joseph Keane, Sharon K. Gershon, Robert P. Wise et al. · New England Journal of Medicine · 2001 · 3.7K citations · Full text

, , +16

Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug Administration

S Brown, Mark H. Greene, Sharon K. Gershon et al. · Arthritis & Rheumatism · 2002 · 661 citations

, , +11

Life‐threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept

Jong‐Hoon Lee, Nancy R. Slifman, Sharon K. Gershon et al. · Arthritis & Rheumatism · 2002 · 448 citations

, , +10

<i>Listeria monocytogenes</i> infection as a complication of treatment with tumor necrosis factor α–neutralizing agents

Nancy R. Slifman, Sharon K. Gershon, Jong‐Hoon Lee et al. · Arthritis & Rheumatism · 2003 · 387 citations

, , +15

How Many Pharmacists Are in Our Future? The Bureau of Health Professions Projects Supply to 2020

Sharon K. Gershon, James M. Cultice, Katherine K. Knapp · Journal of the American Pharmaceutical Association (1996) · 2000 · 27 citations

, , +9

1–5 of 7